Announce Date | 04/22/2025 |
EPS Normalized Actual | $2.31 (Beat by $0.1) |
EPS GAAP Actual | $2.31 (Beat by $0.1) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.32 |
EPS GAAP Estimate | $2.32 |
Revenue Estimate | $2.1153B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 15.72 | 12.85 | 15.43602 | 16.13442 | 1 |
Dec 2028 | 13.59 | 14.86 | 13.31653 | 13.84021 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.27 | 0.34 | 0B | -INF% | -1900.9M |
FQ4 2024 (Dec 2024) | 0 | -2.34879 | 2.1461B | 9.7% | 99.22M |
FQ3 2024 (Sep 2024) | 2.65 | 2.65 | 2.1824B | 11.29% | 2182.4M |
FQ2 2024 (Jun 2024) | 2.22 | 2.22 | 2.0753B | 5.94% | 2075.3M |
FQ1 2024 (Mar 2024) | 1.63 | 1.63 | 1.9795B | 0.16% | 1979.5M |
FQ4 2023 (Dec 2023) | 2.1 | 2.1 | 1.9379B | -2.09% | 1937.9M |
FQ3 2023 (Sep 2023) | 2.04 | 2.04 | 1.936B | -9.81% | 1936M |
FQ2 2023 (Jun 2023) | 2.25 | 2.25 | 1.9521B | -14.61% | 1952.1M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.32
Consensus Revenue Estimates
2.1153B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.07963 | -- | 2.98813 | 3.20413 | 2 |
FQ2 2027 (Jun 2027) | 2.82757 | -- | 2.74356 | 2.94188 | 2 |
FQ1 2027 (Mar 2027) | 2.57066 | -- | 2.49428 | 2.67459 | 3 |
FQ4 2026 (Dec 2026) | 2.81 | -- | 2.67624 | 2.89877 | 1 |
FQ3 2026 (Sep 2026) | 3.28 | -- | 3.12387 | 3.38362 | 1 |
FQ2 2026 (Jun 2026) | 3.32 | -- | 3.16196 | 3.42488 | 1 |
FQ1 2026 (Mar 2026) | 2.63 | 13.69 | 2.50481 | 2.71308 | 1 |
FQ4 2025 (Oct 2025) | 2.76 | -- | 2.66243 | 2.86238 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.52B | -- | 2.46B | 2.6B | 3 |
FQ2 2027 (Jun 2027) | 2.39B | -- | 2.33B | 2.46B | 3 |
FQ1 2027 (Mar 2027) | 2.26B | -- | 2.21B | 2.33B | 4 |
FQ4 2026 (Dec 2026) | 2.35B | -- | 2.26B | 2.41B | 2 |
FQ3 2026 (Sep 2026) | 2.33B | -- | 2.25B | 2.39B | 2 |
FQ2 2026 (Jun 2026) | 2.31B | -- | 2.23B | 2.37B | 2 |
FQ1 2026 (Mar 2026) | 2.29B | -- | 2.21B | 2.35B | 2 |
FQ4 2025 (Oct 2025) | 2.21B | 3.04 | 2.15B | 2.28B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.93 | 2.27 | 0.34 | 14.98% |
FQ4 2024 (Dec 2024) | 2.34879 | 0 | -2.34879 | -INF% |
FQ3 2024 (Sep 2024) | 2.65 | 2.65 | 100% | |
FQ2 2024 (Jun 2024) | 2.22 | 2.22 | 100% | |
FQ1 2024 (Mar 2024) | 1.63 | 1.63 | 100% | |
FQ4 2023 (Dec 2023) | 2.1 | 2.1 | 100% | |
FQ3 2023 (Sep 2023) | 2.04 | 2.04 | 100% | |
FQ2 2023 (Jun 2023) | 2.25 | 2.25 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.9B | $0B | $-1900.9M | -INF% |
FQ4 2024 (Dec 2024) | $2.05B | $2.15B | $99.22M | 4.62% |
FQ3 2024 (Sep 2024) | $0B | $2.18B | $2182.4M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.08B | $2075.3M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.98B | $1979.5M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.94B | $1937.9M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.94B | $1936M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.95B | $1952.1M | 100% |